Scientists have developed a CRISPR-based technology that could offer a safer approach to correcting genetic defects. The new “soft” CRISPR system makes use of natural DNA repair machinery, providing a foundation for novel gene therapy strategies with the potential to cure genetic diseases.
Related Articles

Serving the Underserved During the Global Pandemic
“A wonderful blessing” is how Donna Beifus describes the partnership between UC San Diego Health and Father Joe’s Villages, a non-profit organization serving more than 13,500 San Diegans each year who are experi… […]

UC San Diego Health Top Ranked by U.S. News & World Report
U.S. News & World Report. The annual ?Best Hospitals? rankings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions. ]]>
… […]

State Stem Cell Agency Awards $4M for Blood Cancer Immunotherapy at UC San Diego
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic. Click here to view original post… […]